29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our objective was to assess the frequency of lipohypertrophy (LH) and its relationship to site rotation, needle reuse, glucose variability, hypoglycaemia and use of insulin.

          Related collections

          Author and article information

          Journal
          Diabetes Metab.
          Diabetes & metabolism
          1878-1780
          1262-3636
          Oct 2013
          : 39
          : 5
          Affiliations
          [1 ] Novartis Pharma, Barcelona, Spain. Electronic address: mblanco.hernandez86@gmail.com.
          Article
          S1262-3636(13)00121-3
          10.1016/j.diabet.2013.05.006
          23886784
          Copyright © 2013 Elsevier Masson SAS. All rights reserved.

          Comments

          Comment on this article